Literature DB >> 33733320

Risk factors of poor prognosis in patients with pyrrolidine alkaloids induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt : Transjugular intrahepatic portosystemic shunt in patients with sinusoidal obstruction syndrome, etiology matters.

Marta Magaz1,2,3, Juan Carlos García-Pagán4,5,6.   

Abstract

Entities:  

Year:  2021        PMID: 33733320     DOI: 10.1007/s12072-021-10166-x

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


× No keyword cloud information.
  1 in total

1.  Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease.

Authors:  Yu Z Zhuge; Yi Wang; Feng Zhang; Cheng K Zhu; Wei Zhang; Ming Zhang; Qibin He; Jian Yang; Jian He; Jun Chen; Xiao P Zou
Journal:  Liver Int       Date:  2018-02-11       Impact factor: 5.828

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.